The recently discovered 150-cavity in the active site of group-1 influenza A neuraminidase (NA) proteins provides a target for rational structure-based drug development to counter the increasing frequency of antiviral resistance in influenza. Surprisingly, the 2009 H1N1 pandemic virus (09N1) neuramidase was crystalized without the 150-cavity characteristic of group-1 NAs. Here we demonstrate, through a total sum of 1.6 µs of biophysical simulations, that 09N1 NA exists in solution preferentially with an open 150-cavity. Comparison with simulations using avian N1, human N2 and 09N1 with a I149V mutation and an extensive bioinformatics analysis suggests that the conservation of a key salt bridge is crucial in the stabilization of the 150-cavity across both subtypes. This result provides an atomic-level structural understanding of the recent finding that antiviral compounds designed to take advantage of contacts in the 150-cavity can inactivate both 2009 H1N1 pandemic and avian H5N1 viruses.
. In particular, I149 was found to be common between the 2009 pandemic N1 and group-2 NAs, whereas V149 was conserved among the other group-1 NAs. In the two solved N2 structures, which have somewhat atypical sequences, a salt bridge between D147 and H150 appeared to prevent the opening of the 150-loop, despite the presence of V149.
Here we test the hypothesis that position 149 is critical for determining the open or closed status of the 150-cavity. Our alternative hypothesis is that cavity status is plastic in the absence of a D147-H150 salt bridge, being dependent on loop conformations that are themselves flexible. Earlier computational studies of N1 from avian H5N1 showed that this isolate exhibited remarkable flexibility in the 150-loop 6 . The same avian N1 was also reported to contain a closed 150-loop under certain crystallization conditions 1 and additionally shown to be able to switch to a closed loop position during a molecular dynamics (MD) simulation initiated from the co-crystallized oseltamivir-bound open-150-loop configuration 6 . The understanding that emerged was that the avian N1 was able to adopt a wide range of configurations in the 150-loop region, favouring an open conformation of the 150-cavity overall. We examined the flexibility of the 150-cavity area in the 09N1 crystal structure through molecular dynamics simulations using 09N1 and other available structures of N1 and N2 alleles derived from human clinical isolates. In combination with the simulations, an extensive bioinformatics analysis for these alleles in the 150-and 430-loop regions offers new clues as to the controlling features of 150-cavity formation in these critical enzymes. Ultimately, we found that a key salt bridge appears to control the 150-cavity formation in both group-1 and group-2 enzymes, both of which are able to adopt flexible loop conformations in this critical region. We propose that this new structural understanding can be related to antiviral design for any of the influenza NA enzymes.
Results

Molecular dynamics simulations.
To probe the effect of sequence on the atomic-level structure and dynamics of these critical enzymes, we performed four separate 100-ns molecular dynamics simulations for four tetrameric NA enzymes: (1) A/California/04/2009, an H1N1 virus isolated early in the 2009 pandemic (09N1, Protein Data Bank (PDB) accession code: 3NSS) 5 . We note that the N1 allele in the pandemic strain had recently evolved from an Eurasianlineage H1N1 swine virus 8 . We note that the I149V mutation in A/Tokyo/3/67 is atypical for a human N2 allele (Table 1; Supplementary Table S1 ).
The homotetramer configuration of NA allows us to take advantage of multicopy simulation sampling 9 , amounting to the equivalent of nearly half a microsecond (400 ns) of sampling for each NA monomer, while accounting for realistic neighbouring subunit effects within the structural dynamics. Alpha-carbon root mean square deviation (RMSD) plots for the tetramer systems and individual monomer chains exhibit stability over 100 ns, and there is good agreement between experimental and simulation-derived B-factors (Supplementary Figs S1-S3).
Pandemic 2009
H1N1 exhibits open 150-cavity. Our simulations reveal that the pandemic 09N1 NA is able to adopt open 150-cavity conformations in normal solution dynamics, and, in contrast to the crystal structure, it appears to favour an open 150-cavity conformation overall ( Fig. 1; Table 1 ). In the simulations of 09N1, the 150-loop transitions to an open configuration by 50 ns in all chains of the tetramer (Supplementary Fig. S4 ). As a reference for open-and closed-loop structures, the PDB accession codes 2HTY and 2HU4 were utilized, respectively. The open 150-cavity crystal structure (2HTY with hydrogen atoms added) exhibits a 150-cavity volume of 36 Å 3 as computed by POVME 10 (Supplementary Table S3 ). Closed 150-cavity crystal structures (1NN2, 2HU4, 3NSS with hydrogen atoms added) were used as references and uniformly exhibit a volume of 0 Å 3 . To quantify the extent to which structures within the dynamical ensemble adopt either a closed or open 150-cavity conformation, a time series of the pocket volume was computed over the course of the trajectory ( Fig. 2a; Supplementary Fig. S5 Table 2 ). We note that longer simulation times may further increase the percentage of 09N1 in the open conformation, overcoming the structural bias due to the simulation being initiated with a closed 150-cavity.
RMSD-based clustering of the 150-loop residues enables an atomic-level population-based structural analysis. Although the most populated cluster, that is, the cluster that comprises at least 33% of the sampled ensemble, has a closed 150-loop configuration, structures within the next two most populated clusters adopt open 150-cavity configurations ( Fig. 1; Supplementary Table S2 ). 
N1 
N2 avian polymorphisms seen since the mid-1990s
Consensus sequences contain amino acids at a frequency of at least 80%. Sequences in bold font correspond to structures simulated in this paper. 
150-Cavity formation controlled by a conserved salt bridge.
The dynamics of the N2 strain reveal that a key salt bridge between conserved residues D147 and H150 controls the formation of the 150-cavity in N2. This ionic contact locks I149 in the space of the 150-cavity (Fig. 3) , as suggested in ref. 5 . However, in each chain of the N2 tetramer simulation, this salt bridge intermittently breaks and then reforms; in chain C, at 60 ns the contact is lost again, after which the open 150-cavity forms, and contact to the 430-loop is lost ( Fig. 2c ; Supplementary Fig. S7 ). The loss of the D147-H150 salt bridge allows the 150-loop to move to the open position, even wider than the VN04N1 open 150-loop structure (Fig. 2) . RMSD-based clustering of the 150-loop indicates that while both the first and second most dominant configurations remain closed, the third most dominant configuration, representing 6.8% of the trajectory, exhibits an open 150-cavity (Fig. 1) . Supplementary Fig. S8) . Although the open 150-loop is energetically accessible in the N2 structures, its low population during the simulation makes it unlikely that this open 150-cavity would appear in X-ray crystallography experiments. Such a cavity would be able to accommodate compounds targeting the 150-cavity, albeit with a lower affinity, as very recently shown in ref. 3 . In all the N1 proteins, D147 is replaced with an uncharged G147, and therefore no salt bridge is present to lock I/V149 in the 150-cavity space. This may explain why an open 150-cavity is characteristically observed in crystals, even in 09N1, which is able to adopt a stable open 150-cavity conformation. It also underscores the importance of considering solution-phase dynamics for these enzymes and not only crystallographic information, which is generally only able to provide one low-energy snapshot of the dynamic protein complex under crystalline conditions. Among N1 alleles for which structures exist, the 2009 H1N1 pandemic isolate uniquely contains an I149. Thus, Li et al. 5 hypothesized that the additional extension of the I149 side chain, compared with V149, may be a compensating factor in controlling the closedloop structure, despite strict conservation of all other residues in this area. Structurally, the longer side chain of I149 may facilitate van der Waals contacts to the neighbouring 430-loop, and shift the population to a more closed 150-loop state; a V149 mutation would facilitate loss of contact between the 150-and 430-loop, shifting the population to a more open 150-cavity state. To test this hypothesis, we created the 09N1_I149V mutant strain in silico and performed an identical 100 ns simulation. Our results indicate that the effect of this mutation on 150-cavity status varies due to 150-loop flexibility. The time series data indicate that the I149V mutation caused chain D to open almost immediately, chain C to open after 60 ns, chain A to open intermittently and had almost no effect on chain B (Supplementary Fig. S9) . Overall, the 09N1_I149V mutant is actually more closed, exhibiting the open 150-cavity less frequently, in only 37.1% of the simulation, compared with the normal 09N1 strain with the I149 present ( Table 2 , Fig. 2d; Supplementary Fig. S9 ). Moreover, only one of the three most dominant structures, cluster 2, presents the open 150-cavity, and thus, the V149 by itself cannot explain the behaviour of the 09N1_I149V.
Analysis of sequence conservation in the 150-loop region.
To date, the evolutionary distribution of the 150-cavity among NA alleles has been inferred primarily from crystallographically resolved structures, which represent a limited subset of the genetic variation of NAs in nature. Based on those analyses, it seemed logical to attribute the occurrence of an open 150-cavity to having a V or I at position 149, and by extension, to membership, in the group-1 or group-2 NAs, respectively, as shown in figure 3 of Li et al. Our dynamical analyses suggest that I/V149 is not as critical to 150-cavity status as the D147-H150 salt bridge, which warrants re-examination of the association of cavity status with NA group membership. We determined the distribution of genetic variation in the 150 and 450 loops among all avian, human and swine N1 and N2 sequences that had been deposited in GenBank and Global Initiative on Sharing Avian Influenza Data (GISAID) as of 12 August 2010 using phylogenetic analysis to construct consensus sequences for each major clade (Supplementary Methods for methodological details).
Our phylogenetic analyses (Table 1) show that no single amino acid position in the 150-or 430-loops clearly differentiates the N1 and N2 alleles, which are in group-1 and group-2, respectively. The D147-H150 salt bridge is not a defining characteristic of N2 alleles, as it is not present in avian viruses, which were the source of the N2 allele in the 1957 H2N2 human pandemic strain. Nor is the salt bridge found in human H3N2 viruses that have been circulating since 2008, due to fixation of a D147N mutation. Thus, neither the amino acid at position 149 nor the salt bridge is fixed characters that differentiate group 1 and group 2 NAs. Nor do they, at least by themselves, characterize viruses capable of infection of humans. Additional tests of our hypothesis require the acquisition of crystal structures of additional NA alleles, most critically, an N2 allele that contains both the D147-H150 salt bridge and I149.
Discussion
Our results highlight the importance of interpreting influenza NA sequence and structural data in light of the dynamical ensemble of conformations that are accessible to each NA protein. This work shows for the first time that both N1 and N2 clinical isolates exhibit flexibility in the 150-cavity neighbouring the conserved sialicacid-binding site. Although it remains possible that the open and closed conformation observed in crystal structures may be due to differences in crystallization conditions or procedures, our results indicate that the presence of the 150-cavity is not a strictly defining characteristic for group-1 or group-2 NA enzymes. Instead, it appears that both N1 and N2 enzymes are able to adopt an open 150-cavity within their solution phase structural ensemble, in various relative populations, which appear to be predominantly controlled by the presence of the D147-H/R150 salt bridge. This suggests a new paradigm for the understanding of the presence of the 150-cavity in both group-1 and group-2 NAs. The inherent flexibility of the 150-and 430-loops may have a role in full glycan receptor recognition, and in particular, with facilitating recognition events with the distal sugar residues of different glycan receptors. It is likely that the opening and closing of the 150-cavity is required for natural sialoglycan substrates to fit into the active site, given the bulky nature of these glycans.
This study additionally underscores the need to consider dynamics in rationalizing the structure-function relationships of various antiviral-NA pairs. Ensemble-based drug discovery approaches 11 that account for full-receptor flexibility towards NAs that do not contain the D147-H150 salt bridge will likely present additional advances in the design of compounds that selectively target the 150-cavity, opening the possibility for receptor-specific inhibitors. In closing, we note that whether the flexibility of the NA-binding site has an impact on receptor specificity, virus transmissibility or pathogenicity remains to be seen and will likely require a better understanding of HA receptor-binding domain dynamics for each of the NA/HA pairs found in humans 12 .
Methods
Simulation protocol. System setup was performed as follows for all simulated systems. Atomic coordinates were taken from 2HTY for A/Vietnam/1203/04 (VN04N1) 1 , 3NSS for A/California/04/2009 (09N1) 5 and 1NN2 for A/Aichi/3/67 (N2) 8 . Protonation states for histidines and other titratable groups were determined at pH 6.5 by the PDB2PQR 13 web server using PROPKA 14 and manually verified. All crystallographically resolved water molecules and calcium ions were retained where possible and taken by homology from 2HTY if not present. The system was setup using the AMBER11 15 program xLeap using the AMBER99SB force field 16 . Disulphide bonds were properly enforced using the CYX notation in AMBER. A 10-12 Å pad of TIP3P waters was added to solvate to each system. Neutralizing counter ions were added to each system. In order to mimic experimental assay conditions, a 20 mM NaCl salt bath was introduced. System details and additional methodological information can be found in the Supplementary information.
N1 and N2 tetramer simulations were performed with a version of the PMEMD module from AMBER 11 that was custom tuned for these specific simulations and the NICS Cray XT4 and SDSC Trestles supercomputers by SDSC under the NSF's TeraGrid Advanced User Support Program. The N1 and N2 apo tetramer complexes were minimized and equilibrated as follows: in order to alleciate any steric clashes before performing molecular dynamics, the structures were minimized in a number of stages in which harmonic restraints of initially 5 kcal mol − 1 Å − 2 on all non-hydrogen protein atoms were slowly reduced over ~40,000 combined steepest descent and conjugate gradient minimization steps.
Following minimization, the system was linearly heated to 310 K in the canonical NVT ensemble (constant number of particles, N; constant volume, V; constant temperature, T) using a Langevin thermostat, with a collision frequency of 5.0 ps . Production runs were then made for 100 ns duration in the NVT ensemble at 310 K. As with the heating, the temperature was controlled with a Langevin thermostat (but with a 1.0 ps − 1 collision frequency). The time step used for all stages was 2 fs and all hydrogen atoms were constrained using the SHAKE algorithm 18 . Long-range electrostatics were included on every step using the Particle Mesh Ewald algorithm 19 with a 4th order B-spline interpolation, a grid spacing of < 1.0 Å, and a direct space cutoff of 8 Å. For all trajectories, the random number stream was seeded using the wall clock time in microseconds. The production trajectories for each monomer of the tetramer were extracted and concatenated to approximate 400 ns of monomer sampling.
RMSD clustering. RMSD clustering was performed as implemented in the rmsdmat2 and cluster2 programs of the GROMOS + + analysis software 20 . A total of 500 tetramer structures were collected by sampling at 200 ps intervals. Monomer structures were then concatenated together, yielding a total of 2,000 structures. Before clustering, external translational and rotational motions were removed by minimizing the RMSD distance of the alpha-carbon atoms of the sampled structure to the equivalent atoms of the first frame of chain A. Using a 2.6 Å cutoff, clustering was then performed using the GROMOS + + clustering algorithm 21 in Gromacs   22 on the alpha-carbon atoms of the 6-residue subset, 146-152, which comprise the 150 loops. Each cluster contains a central structure, or 'cluster representative member, ' called the 'centroid, ' whose RMSD is equidistant to all other cluster members. The cluster representative's structural properties are considered characteristic of all cluster members. Cluster results are summarized in Table 2 .
RMSD and B-factor calculations. B-factor calculations, as well as tetramer and monomer RMSD time series, were performed using the ptraj analysis tool in the AMBER 10 program suite 23 . Structures were sampled at 20 ps intervals. Before performing each calculation, external translational and rotational motions were removed by minimizing the RMSD distance of the alpha-carbon atoms to the equivalent atoms of the first frame of the trajectory. RMSD and B-factor values were calculated for alpha-carbon atoms.
09N1 RMSD 150-loop measurements. RMSD values were measured using a custom, hand-written script in the VMD TCL-TK console 24 . Structures were sampled at 20 ps intervals. Sampled structures of each monomer were RMSD-aligned by alpha-carbon to the equivalent alpha-carbon atoms of the 'reference' structure: Interatomic distance measurements. The distance separating the salt bridge pair ASP147 and HIS150 was measured using a custom, hand-written script in the VMD TCL-TK console. Structures were sampled at 20 ps intervals. The distance between the two residues was defined as the distance separating centres of mass of the heavy atoms of the ASP147 carboxylate and the HIS 150 imidazole. The distance between residues 149 and 431 were measured for each step using a custom VMD script.
Neuraminidase volume population analysis. The numbers of open or closed 150-cavity conformations out of a total of 2,000 snapshots were computed. Any instantaneous volume equal to or greater than half the volume of the crystal structure of canonical group-1 serovar (2HTY exhibits a total 150-cavity volume of 36 Å 3 ) is considered to be 'open' . Otherwise the 150-cavity is considered 'closed' (that is, when it exhibits < 18 Å 3 ). The volume of the 150-cavity was measured for each step by using POVME 10 ; a pocket volume measuring algorithm. To measure the volume, we used a single inclusion sphere that encompassed the 150-cavity. The POVME algorithm neglected the volume occupied by NA atoms and not spatially contiguous with a point specified within the 150-cavity. By rotating 90° around the NA tetramer central axis, each of the other three 150-cavity sites were specified. The volume was thus measured for every snapshot of the simulation on all four chains of each NA.
Figures and plots.
Matlab was used to generate all plots and molecular images were created using VMD 24 .
Consensus sequences. We downloaded all influenza A N1 and N2 gene sequences from humans, avians and swine that were > 600 bp in length from GenBank and GISAID on 12 August 2010. We aligned sequences using ClustalX 2.0 (ref. 25) and constructed phylogenetic trees using MrBayes version 3. 
